Seeking Alpha

Seeking Alpha Portfolio App for iPad

320 people get HTWR articles and Market Currents by email alert.

Get email alerts on HTWR »

HTWR

Heartware International, Inc.

5/21/2013, 8:26 AM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, April 30, 9:10 AM Premarket gainers: HPY +10%. HTWR +9%. ANAD +9%. AVP +8%. UBS +7%. BBY +6%.
Losers: DCTH -20%. AVEO -16%. NUAN -15%. PBI -10%. MTG -8%. CNH -6%. RVBD -6%. QGEN -5%. Comment! [On the Move]
Monday, April 29, 6:19 PM More on HeartWare International (HTWR): Q1 beats across the board on an 87% jump in total sales. Net losses narrowed on U.S. sales of its implantable heart pumps. The company sold a record 482 HVAD pumps globally in the latest period, up from 298 units in Q112 and surpassing its previous high quarterly total of 345 in Q412. Gross margin widened to 61.9% from 58.9%. Shares +7.7% AH. Comment! [Healthcare, Earnings, On the Move]
Monday, April 29, 6:16 PM HeartWare (HTWR): Q1 EPS of -$0.87 beats by $0.34. Revenue of $49.2M beats by $9.52M. (PR) Comment! [Earnings, Breaking News]
Monday, April 29, 6:13 PM HeartWare International (HTWR): Q1 EPS loss of $0.87 beats by $0.33. Revenue of $49.2M (+87% Y/Y) beats by $9.2M. (PR) Shares +7% AH. Comment! [Healthcare, Earnings, On the Move, Breaking News]
Monday, April 29, 5:38 PM After-hours top gainers, as of 5:15 p.m.: HTWR +9%. TXRH +8%. MGT +3%. USLV +3%. BWLD +2%.
After-hours top losers: MCO -8%. RVBD -7%. NSPR -7%. MBI -6%. BAH -3%. 1 Comment [On the Move]
Tuesday, March 12, 3:15 PM HeartWare International (HTWR -2%) trades lower today after the maker of surgically implanted pumps announced plans to sell 1.5M shares. The company plans to use the new funds for working capital and general corporate purposes, including research and development and expanding its manufacturing facilities. Comment! [Healthcare, On the Move]
Wednesday, February 27, 7:37 AM HeartWare International Inc (HTWR): Q4 EPS of -$1.46. Revenue of $32.7M (+42% Y/Y). (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, November 21, 2012, 12:28 PM Thoratec (THOR +5.3%) trades higher today after Wells Fargo ups the shares to Outperform and raises its valuation by roughly 20%. The move comes a day after the FDA approved rival HeartWare International's (HTWR -5.4%) heart-pumping device, and Wells notes that THOR's competing product showed a lower incidence of stroke in recent trials. Comment! [Healthcare, On the Move]
Tuesday, November 20, 2012, 3:13 PM HeartWare (HTWR +7.5%) soars after the company's implantable heart pump receives FDA approval. (PR) Comment! [Healthcare, On the Move]
Thursday, April 26, 2012, 9:25 AM HeartWare's (HTWR) +15.5% premarket on news the company's implantable pump for heart-transplant candidates wins the backing of an FDA advisory panel. If HTWR's Ventricular Assist System also is approved for patients who aren’t eligible for a transplant, the company could split the U.S. market with Thoratec’s (THOR) HeartMate device by 2015, analysts say. Comment! [Healthcare, On the Move]
Thursday, April 26, 2012, 9:20 AM Premarket gainers: PATK +26%. HTWR +15%. REGN +14%. NUAN +14%. LOGI +14%. VHC +12%. CTXS +12%. NRGY +10%. EQIX +9%. CRUS +8%. SPPI +8%. INCY +7%. XLNX +7%. WPI +7%. AMRN +5%. EA +7%. MWW +5%. AH +6%. PHM +6%. AIS +5%. AIXG +5%. LSI +4%. TS +3%. UN +3%. ZNGA +3%. FRO +3%. RDS +3%.
Losers: FURX -28%. PCS -15%. HRB -15%. TQNT -14%. ALU -13%. TSPT -12%. AET -9%. PTX -7%. AKAM -6%. AZN -6%. ZMH -5%. DB -5%. HERO -5%. STD -5%. DOW -4%. CELG -4%. CS -4%. CROX -4%. GG -3%. BWA -3%. UNH -3%. LVS -3%. VALE -3%. UPS -3%. POT -3%. Comment! [On the Move]
Monday, April 23, 2012, 10:09 AM HeartWare (HTWR +5.5%) beating strongly after the FDA says the firm's blood pump appears to aid patients with severe heart failure. However, the agency raises safety concerns about clotting rates and stroke, and says the clinical trials may have missing data and are difficult to compare. An FDA advisory panel is due to vote on the device on Wednesday. Comment! [Healthcare, On the Move]
Thursday, March 29, 2012, 7:32 PM HeartWare International (HTWR) acquires World Heart (WHRT), a developer of of left ventricular assist heart devices, for $8M in an all stock transaction. WHRT +3.7% AH. 1 Comment [Healthcare, M&A]
Friday, March 16, 2012, 11:32 AM Heartware (HTWR -0.3%) gets approval from the FDA to enroll 54 patients in a clinical trial of its "bridge" to a heart transplantation for patients with heart failure. The FDA Circulatory System Devices Panel is slated to review the firm's application to move forward with its ventricular assist system on April 25. Comment! [Healthcare]
Tuesday, February 14, 2012, 12:42 PM HeartWare (HTWR +1.9%) moves higher after an FDA panel says it will review the Premarket Approval application for the company's Ventricular Assist System on April 25. Leerink Swann says the overhang in the shares has been removed following the news, and it believes a Q3 approval and launch is likely. Comment! [Healthcare, On the Move]
Thursday, January 5, 2012, 3:51 PM Thoratec (THOR -3.8%) trades down after UBS cut the shares to Neutral from Buy on valuation. The firm says the stock may be played out over the near term, as peer competitor Heartware's (HTWR +1%) pending launch of HVAD is expected to cut into its heart therapy market share. Comment! [Healthcare, On the Move]